TH
Therapeutic Areas
EveliQure Biotechnologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ShigETEC | Shigellosis and Enterotoxigenic E. coli (ETEC) infection | Phase 2b |
Leadership Team at EveliQure Biotechnologies
GS
Gábor Somogyi, MD, MBA
Chief Executive Officer
FM
Frank Malinoski, MD, PhD
Chief Medical Officer
PG
Petra Girardi, PhD
Program Director